The risk of gastrointestinal perforation and/or fistula in patients with recurrent ovarian cancer receiving bevacizumab compared to standard chemotherapy: A retrospective cohort study

✍ Scribed by Gregory P. Sfakianos; T. Michael Numnum; Caitlin B. Halverson; Deepa Panjeti; James E. Kendrick IV; J. Michael Straughn Jr.

• Book ID: 113962096
• Publisher: Elsevier Science
• Year: 2009
• Tongue: English
• Weight: 115 KB
• Volume: 114
• Category: Article
• ISSN: 0090-8258
• DOI: 10.1016/j.ygyno.2009.05.031